Shilpa Medicare Ltd's finished dosage form manufacturing facility, Unit IV, situated at Pharma SEZ, Jadcherla, Telangana has received Health Canada GMP approval
He brings over 30 years of experience across various organizations such as Asian Paints PPG, Berger Paints, Tata Steel, among others
The company had responded to the agency and carried out the required corrective actions.
The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year
The two overhead tanks commissioned at a cost of Rs 57 lakh will be maintained by the village panchayats.
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
Thalassemia and Sickle Cell Society (TSCS) always stands forefront in providing blood transfusion free of cost for Thalassemia Blood disorders patients
iNCOVACC was developed in partnership with Washington University St. Louis, which had designed and developed the recombinant adenoviral vectored constructs and evaluated them in preclinical studies for efficacy
The drive also conducted a mega health camp, cancer screening for women and men, ENT screening for children, and blood donation drive
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
Subscribe To Our Newsletter & Stay Updated
